Clinical Trial Update: Study of Biodistribution, Metabolism, Excretion and Brain Uptake11C-M503 [EARLY_Phase 1]

View source ↗

Summary

This early Phase 1 trial update describes a study of the radiotracer 11C-M503 to assess its biodistribution, metabolism, excretion, and brain uptake in tauopath…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Tauopathies

Drugs mentioned

• 11C-M503

Snippet

Sponsor: University of Pennsylvania | Conditions: Tauopathies | EARLY_Phase 1 | Status: RECRUITING